a/b testing Why no serious researchers conduct "per protocol" analyses Or, the importance of random treatment assignment
Chapter 4 Why FDA says stick to the test Kaiser explains why FDA doesn't think we should just start swabbing our throats instead of our noses.
Bias Further adventures of case-counting windows Kaiser discusses several observations from the Israel booster study.
Assumptions Blood clots: is there a there Kaiser looks at the controversy over blood clots and the Astrazeneca vaccine.
Cause-effect Real-world studies: limits of knowledge Kaiser focuses attention on a few aspects of the Mayo Clinic real-world effectiveness study.